Transgenic mouse models in angiogenesis and cardiovascular disease

P Carmeliet1, D Collen

  • 1Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KU Leuven, Leuven, B-3000, Belgium. peter.carmeliet@med.kuleuven.ac.be

The Journal of Pathology
|February 24, 2000
PubMed
Summary

Gene technologies enable precise genetic manipulation in mice to study disease mechanisms and test gene therapies. This research advances understanding of blood vessel formation and disease, utilizing transgenic models and advanced assays.